Arkolith/Insider Trading/CMPX/Form 4

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER, DirectorCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed Aug 2, 2022
Net Buying
Open-Market Buys
$39K
Open-Market Sells
$0
Net Open-Market Flow
$39K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2022Buy(P)15K$2.58$39K5.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-22-005231) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML